Israel Englander Syros Pharmaceuticals, Inc. Transaction History

Millennium Management LLC

  • $207 Billion
  • Q2 2024

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$0.69 - $1.21 $312,067 - $547,249
452,272 Added 88.36%
964,096 $928,000
Q1 2022

May 16, 2022
BUY
$1.02 - $3.8 $427,914 - $1.59 Million
419,524 Added 454.52%
511,824 $609,000
Q4 2021

Feb 14, 2022
SELL
$3.26 - $4.66 $730,484 - $1.04 Million
-224,075 Reduced 70.83%
92,300 $301,000
Q3 2021

Nov 15, 2021
SELL
$4.08 - $5.66 $984,659 - $1.37 Million
-241,338 Reduced 43.27%
316,375 $1.41 Million
Q2 2021

Aug 16, 2021
BUY
$5.01 - $7.48 $1.95 Million - $2.91 Million
388,920 Added 230.41%
557,713 $3.04 Million
Q1 2021

May 17, 2021
SELL
$7.19 - $14.95 $1.52 Million - $3.16 Million
-211,473 Reduced 55.61%
168,793 $1.26 Million
Q4 2020

Feb 16, 2021
BUY
$6.66 - $14.66 $1.53 Million - $3.36 Million
229,240 Added 151.79%
380,266 $4.13 Million
Q3 2020

Nov 16, 2020
SELL
$8.69 - $14.47 $17,701 - $29,475
-2,037 Reduced 1.33%
151,026 $1.34 Million
Q2 2020

Aug 14, 2020
BUY
$5.21 - $11.03 $797,458 - $1.69 Million
153,063 New
153,063 $1.63 Million
Q1 2020

May 14, 2020
SELL
$4.46 - $9.2 $2.34 Million - $4.84 Million
-525,585 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$4.52 - $10.1 $2.29 Million - $5.12 Million
506,810 Added 2699.39%
525,585 $3.63 Million
Q3 2019

Nov 14, 2019
BUY
$7.14 - $11.65 $134,053 - $218,728
18,775 New
18,775 $194,000
Q2 2019

Aug 14, 2019
SELL
$5.5 - $9.75 $383,432 - $679,721
-69,715 Closed
0 $0
Q1 2019

May 14, 2019
SELL
$5.51 - $9.59 $145,849 - $253,847
-26,470 Reduced 27.52%
69,715 $637,000
Q4 2018

Feb 14, 2019
SELL
$5.55 - $11.34 $425,468 - $869,335
-76,661 Reduced 44.35%
96,185 $536,000
Q3 2018

Nov 14, 2018
SELL
$9.74 - $12.92 $1.97 Million - $2.62 Million
-202,620 Reduced 53.96%
172,846 $2.06 Million
Q2 2018

Aug 14, 2018
BUY
$10.16 - $13.65 $2.15 Million - $2.89 Million
211,696 Added 129.26%
375,466 $3.83 Million
Q1 2018

May 15, 2018
BUY
$9.47 - $12.98 $1.55 Million - $2.13 Million
163,770 New
163,770 $2.13 Million
Q4 2017

Feb 14, 2018
SELL
$8.45 - $17.48 $956,590 - $1.98 Million
-113,206 Closed
0 $0
Q3 2017

Nov 14, 2017
BUY
$13.52 - $23.75 $1.53 Million - $2.69 Million
113,206
113,206 $1.67 Million

About Syros Pharmaceuticals, Inc.

SYRS Quotes by TradingView
  • Ticker SYRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,236,200
  • Market Cap $43.1M
  • Description
  • Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...
More about SYRS
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email